[Amplification and expression of HER-2 oncogene in precancerous stages and cancers of the endometrium].
Czerwenka
K F
KF
I. Univers.-Frauenklinik, Wien.
Heuss
F
F
Zeillinger
R
R
Hosmann
J W
JW
Wagner
T
T
Manavi
M
M
Jelincic
D
D
Lu
Y
Y
Kubista
E
E
D018269:Carcinoma, Endometrioid / Q000235:genetics / Q000473:pathology; D002471:Cell Transformation, Neoplastic / Q000235:genetics* / Q000473:pathology; D004273:DNA, Neoplasm / Q000235:genetics; D004714:Endometrial Hyperplasia / Q000235:genetics / Q000473:pathology; D016889:Endometrial Neoplasms / Q000235:genetics* / Q000473:pathology; D004717:Endometrium / Q000473:pathology; D066246:ErbB Receptors / Q000235:genetics*; D005260:Female; D005784:Gene Amplification / Q000235:genetics*; D015972:Gene Expression Regulation, Neoplastic / Q000502:physiology; D006801:Humans; D011003:Ploidies; D011230:Precancerous Conditions / Q000235:genetics* / Q000473:pathology; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D018719:Erb-b2 Receptor Tyrosine Kinases; D002583:Uterine Cervical Neoplasms / Q000235:genetics / Q000473:pathology
D004273:DNA, Neoplasm; D066246:ErbB Receptors; D011518:Proto-Oncogene Proteins; D018719:Erb-b2 Receptor Tyrosine Kinases
Amplifikation und Expression des HER-2 Onkogens in Karzinomvorstadien und Karzinomen des Endometriums.